GA(2)LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.

Zuberbier T, Muraro A, Nurmatov U, Arasi S, Stevanovic K, Anagnostou A, Bonaguro R, Chinthrajah S, Lack G, Fiocchi A, Le TM, Turner P, Lozano MA, Angier E, Barni S, Bégin P, Ballmer-Weber B, Cardona V, Bindslev-Jensen C, Cianferoni A, de Jong N, de Silva D, Deschildre A, Galvin AD, Ebisawa M, Fleischer DM, Gerdts J, Giovannini M, Gradman J, Halken S, Arshad SH, Khaleva E, Lau S, Loh R, Mäkelä MJ, Marchisotto MJ, Morandini L, Mortz CG, Nilsson C, Nowak-Wegrzyn A, Podestà M, Poulsen LK, Roberts G, Rodríguez Del Río P, Sampson HA, Sánchez A, Schnadt S, Smith PK, Szajewska H, Mitrevska NT, Toniolo A, Venter C, Warner A, Wong GWK, Wood R, Worm M

Open source

DOI
10.1002/clt2.70002
Published
2024 Nov
Container
Clinical and translational allergy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/clt2.70002,
  title = {GA(2)LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.},
  author = {Zuberbier T and Muraro A and Nurmatov U and Arasi S and Stevanovic K and Anagnostou A and Bonaguro R and Chinthrajah S and Lack G and Fiocchi A and Le TM and Turner P and Lozano MA and Angier E and Barni S and Bégin P and Ballmer-Weber B and Cardona V and Bindslev-Jensen C and Cianferoni A and de Jong N and de Silva D and Deschildre A and Galvin AD and Ebisawa M and Fleischer DM and Gerdts J and Giovannini M and Gradman J and Halken S and Arshad SH and Khaleva E and Lau S and Loh R and Mäkelä MJ and Marchisotto MJ and Morandini L and Mortz CG and Nilsson C and Nowak-Wegrzyn A and Podestà M and Poulsen LK and Roberts G and Rodríguez Del Río P and Sampson HA and Sánchez A and Schnadt S and Smith PK and Szajewska H and Mitrevska NT and Toniolo A and Venter C and Warner A and Wong GWK and Wood R and Worm M},
  year = {2024},
  journal = {Clinical and translational allergy},
  doi = {10.1002/clt2.70002},
  url = {https://doi.org/10.1002/clt2.70002}
}

RIS

TY  - JOUR
TI  - GA(2)LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.
AU  - Zuberbier T
AU  - Muraro A
AU  - Nurmatov U
AU  - Arasi S
AU  - Stevanovic K
AU  - Anagnostou A
AU  - Bonaguro R
AU  - Chinthrajah S
AU  - Lack G
AU  - Fiocchi A
AU  - Le TM
AU  - Turner P
AU  - Lozano MA
AU  - Angier E
AU  - Barni S
AU  - Bégin P
AU  - Ballmer-Weber B
AU  - Cardona V
AU  - Bindslev-Jensen C
AU  - Cianferoni A
AU  - de Jong N
AU  - de Silva D
AU  - Deschildre A
AU  - Galvin AD
AU  - Ebisawa M
AU  - Fleischer DM
AU  - Gerdts J
AU  - Giovannini M
AU  - Gradman J
AU  - Halken S
AU  - Arshad SH
AU  - Khaleva E
AU  - Lau S
AU  - Loh R
AU  - Mäkelä MJ
AU  - Marchisotto MJ
AU  - Morandini L
AU  - Mortz CG
AU  - Nilsson C
AU  - Nowak-Wegrzyn A
AU  - Podestà M
AU  - Poulsen LK
AU  - Roberts G
AU  - Rodríguez Del Río P
AU  - Sampson HA
AU  - Sánchez A
AU  - Schnadt S
AU  - Smith PK
AU  - Szajewska H
AU  - Mitrevska NT
AU  - Toniolo A
AU  - Venter C
AU  - Warner A
AU  - Wong GWK
AU  - Wood R
AU  - Worm M
PY  - 2024
JO  - Clinical and translational allergy
DO  - 10.1002/clt2.70002
UR  - https://doi.org/10.1002/clt2.70002
ER  -

APA

T, Z., A, M., U, N., S, A., K, S., A, A., R, B., S, C., G, L., A, F., TM, L., P, T., MA, L., E, A., S, B., P, B., B, B., V, C., C, B., A, C., N, D. J., D, D. S., A, D., AD, G., M, E., DM, F., J, G., M, G., J, G., S, H., SH, A., E, K., S, L., R, L., MJ, M., MJ, M., L, M., CG, M., C, N., A, N., M, P., LK, P., G, R., P, R. D. R., HA, S., A, S., S, S., PK, S., H, S., NT, M., A, T., C, V., A, W., GWK, W., R, W., & M, W. (2024). GA(2)LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.. Clinical and translational allergy. https://doi.org/10.1002/clt2.70002

Source records